IPA (ImmunoPrecise Antibodies)
Year Established:
1989 |
|
Website:
ipatherapeutics.com |
|
Company Type:
Mid-Sized Business (10-100M TTM Revenue) |
|
Completed Requests:
29 |
|
Open Requests:
24 |
|
Certifications:
|
Proprietary Technologies Developed for Your Success
ImmunoPrecise Antibodies (IPA) accelerates therapeutic antibody discovery by offering a full suite of innovative technologies yielding superior candidate diversity and out-performing traditional methods.
Immunization:
• DNA, protein, peptide, whole cell immunization
• Proprietary immunization methods, including rapid protocols
• Species include mouse, rat, camelid, rabbit, chicken, goat, more…
• Proven success with multiple transgenic species/strains
Antibody Discovery:
• Expedited discovery through our superior B cell selection technology
• Advanced custom and in-house phage library screening
• Human and naïve llama libraries (VHH and scFv) available
• Rodent and rabbit monoclonal development
• State-of-the-art hybridoma generation, including semi-solid media and clone picking
Completing the Full Value Chain:
• Characterization
• Engineering and humanization
• Optimization
• Bi-specifics development and manufacturing
• Recombinant protein manufacturing
• Pre-clinical studies
Media
Site | Badges | |
---|---|---|
ImmunoPrecise Antibodies (Europe) BV - Oss Building OP Oss, AB, 5349 Netherlands | ||
ImmunoPrecise Antibodies (Canada) Ltd. #3204-4464 Markham Street Victoria, BC, V8Z 7X8 Canada | ||
ImmunoPrecise Antibodies (Europe) BV - Utrecht Accelerator Building 10th Floor Utrecht, Utrecht CT, 3584 Netherlands |
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.